Literature DB >> 7060313

Age and phenytoin kinetics in adult epileptics.

L A Bauer, R A Blouin.   

Abstract

Michaelis-Menten parameters for rate of drug metabolism (Vmax) and serum concentration at which metabolism is half of Vmax (Km) were determined in 92 adult epileptic patients taking phenytoin who were 21 to 78 yr old. The patients received no known inhibitors or inducers of phenytoin metabolism. Results of physical examinations and tests of liver function and total bilirubin and albumin concentration were normal. Divided into age groups, Vmax values were 7.5 +/- 2.2, 6.6 +/- 1.8, and 6.0 +/- 1.9 mg/kg/day for the 20- to 39-, 40- to 59-, and 60- to 79-yr-old subjects, respectively. Values for those in the 60- to 79-yr-old group were substantially less than those for the youngest subjects (20- to 39-yr-olds; P less than 0.05). Linear regression analysis indicated a decline in Vmax with age (r = 0.518). Km values did not appear to be influenced by age; means ranged from 5.4 to 5.8 microgram/ml. As a result of these changes, the 60- to 79-yr-old group would require, on the average, 21% less phenytoin per day than the 20- to 39-year-olds to maintain a steady-state concentration of 15 microgram/ml. First doses can be based on these data and maintenance doses arrived at based on clinical response.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060313     DOI: 10.1038/clpt.1982.37

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  22 in total

Review 1.  Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors:  M Levine; T Chang
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  The 'apparent clearance' of free phenytoin in elderly vs. younger adults.

Authors:  Daniel F B Wright; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

Review 3.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

4.  Applying organ clearance concepts in a clinical setting.

Authors:  Jorge Duconge
Journal:  Am J Pharm Educ       Date:  2008-10-15       Impact factor: 2.047

Review 5.  Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.

Authors:  James H Fischer; Tejal V Patel; Patricia A Fischer
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 6.  Clinical trials in the elderly. Should we do more?

Authors:  H J Cameron; B O Williams
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 7.  Epilepsy in the elderly.

Authors:  J Godfrey
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

Review 8.  Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations.

Authors:  I Bernus; R G Dickinson; W D Hooper; M J Eadie
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

Review 9.  Differential kinetics of phenytoin in elderly patients.

Authors:  K A Bachmann; R J Belloto
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

Review 10.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.